Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
Phase 4
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2019-05-31
- Last Posted Date
- 2021-08-30
- Lead Sponsor
- Consano Clinical Research, LLC
- Target Recruit Count
- 67
- Registration Number
- NCT03970044
- Locations
- 🇺🇸
Consano Clinical Research, LLC, Shavano Park, Texas, United States
News
No news found